Sangamo Therapeutics
SGMO
#10542
Rank
โ‚ฌ26.54 M
Marketcap
0,06408ย โ‚ฌ
Share price
0.00%
Change (1 day)
-83.04%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: โ‚ฌ26.54 Million

As of August 2026 Sangamo Therapeutics has a market cap of โ‚ฌ26.54 Million. This makes Sangamo Therapeutics the world's 10542th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ26.54 M-78.19%
2025โ‚ฌ0.12 B-76.28%
2024โ‚ฌ0.51 B488.9%
2023โ‚ฌ87.16 M-81.83%
2022โ‚ฌ0.47 B-50.27%
2021โ‚ฌ0.96 B-46.24%
2020โ‚ฌ1.79 B107.09%
2019โ‚ฌ0.86 B-15.5%
2018โ‚ฌ1.02 B-11.24%
2017โ‚ฌ1.15 B464.13%
2016โ‚ฌ0.20 B-65.14%
2015โ‚ฌ0.58 B-31.98%
2014โ‚ฌ0.86 B37.96%
2013โ‚ฌ0.62 B159.69%
2012โ‚ฌ0.24 B110.08%
2011โ‚ฌ0.11 B-49.34%
2010โ‚ฌ0.22 B21.84%
2009โ‚ฌ0.18 B82.26%
2008โ‚ฌ0.10 B-71.63%
2007โ‚ฌ0.35 B105.1%
2006โ‚ฌ0.17 B68.55%
2005โ‚ฌ0.10 B-6.96%
2004โ‚ฌ0.11 B3.1%
2003โ‚ฌ0.10 B52.19%
2002โ‚ฌ71.23 M-72.49%
2001โ‚ฌ0.25 B-43.52%
2000โ‚ฌ0.45 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ543.03 B 2,045,266.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ193.91 B 730,285.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ26.51 B 99,779.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚ฌ19.03 B 71,586.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ142.52 B 536,734.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ279.27 B 1,051,800.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ25.09 B 94,408.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ11.47 B 43,132.65%๐Ÿ‡บ๐Ÿ‡ธ USA